Bayer’s KERENDIA® (finerenone) Receives New Recommendations From American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients With Chronic Kidney Disease Associated With Type 2 Diabetes - Yahoo Finance
6/28/2022 12:00:00 AM3 years 8 months ago
by Business Wire
by Business Wire
WHIPPANY, N.J., June 28, 2022--Bayer’s KERENDIA® (finerenone) was recognized by the American Diabetes Association (ADA) Standards of Medical Care in Diabetes...
- New grade A recommendation in updated ADA Standards of Medical Care in Diabetes2022 for KERENDIA® (finerenone) for improving cardiovascular (CV) outcomes and reducing risk of chronic kidney d… [+20825 chars] full article...